Showing results (1461-1470 of 1,590) with videos related to

Sort By:
Pageof 159
Anti-Cancer Drugs|August 13, 2005
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBCG von Minckwitz, I Chernozemsky, L Sirakova, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2012
Observational study mortality in treated primary aldosteronism: the German Conn's registryMartin Reincke, Evelyn Fischer, Sabine Gerum, et al.
The International Journal of Artificial Organs|February 4, 2022
Comparative analysis of LVAD patients in regard of ischaemic or idiopathic cardiomyopathy: A propensity-score analysis of EUROMACS dataJulia Merkle-Storms, Ilija Djordjevic, Anton Sabashnikov, et al.
Bone|June 8, 2006
Silk based biomaterials to heal critical sized femur defectsL Meinel, O Betz, R Fajardo, et al.
European Urology Focus|February 24, 2024
Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING)Christian Wetterauer, Marc Matthias, Heike Pueschel, et al.
Research Square|October 1, 2025
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated waterJeffrey R Brender, Julian C Assmann, Don E Farthing, et al.
Scientific Reports|September 7, 2023
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated waterJeffrey R Brender, Julian C Assmann, Don E Farthing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast GroupGunter von Minckwitz, Günter Raab, Angelika Caputo, et al.
Bone|October 14, 2003
Localized insulin-like growth factor I delivery to enhance new bone formationLorenz Meinel, Evangelos Zoidis, Jürgen Zapf, et al.
Prehospital Emergency Care|May 29, 2024
Feasibility and Safety of Oral Risperidone to Treat Prehospital AgitationNicholas S Simpson, Alexander M Schin, Michael C Perlmutter, et al.
Pageof 159